摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

lin-benzoguanine | 60064-29-1

中文名称
——
中文别名
——
英文名称
lin-benzoguanine
英文别名
6-Amino-3,7-Dihydro-Imidazo[4,5-G]quinazolin-8-One;6-amino-1,7-dihydroimidazo[4,5-g]quinazolin-8-one
lin-benzoguanine化学式
CAS
60064-29-1
化学式
C9H7N5O
mdl
——
分子量
201.187
InChiKey
VQSMWFVKBKMHTO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >300 °C(Solv: N,N-dimethylformamide (68-12-2); water (7732-18-5))
  • 沸点:
    632.5±47.0 °C(Predicted)
  • 密度:
    1.91±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    96.2
  • 氢给体数:
    3
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933990090

SDS

SDS:3084e9f1e08a4b5786fdcaf967797e3e
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis, Biological Evaluation, and Crystallographic Studies of Extended Guanine-Based (lin-Benzoguanine) Inhibitors for tRNA-Guanine Transglycosylase (TGT)
    作者:Emmanuel A. Meyer、Nicola Donati、Marine Guillot、W. Bernd Schweizer、François Diederich、Bernhard Stengl、Ruth Brenk、Klaus Reuter、Gerhard Klebe
    DOI:10.1002/hlca.200690062
    日期:2006.4
    This paper describes the rational design, synthesis, and biological evaluation of a new generation of inhibitors of the bacterial enzyme tRNA-guanine transglycosylase (TGT), which has been identified as a new target in the fight against bacillary dysentery (Shigellosis). The enzyme catalyzes the exchange of guanine in the anticodon wobble position of tRNA by the modified base preQ1, a guanine derivative
    本文描述了新一代细菌酶tRNA-鸟嘌呤转糖基酶(TGT)抑制剂的合理设计,合成和生物学评估,该抑制剂已被确定为对抗细菌性痢疾(志贺氏菌病)的新目标。根据涉及共价TGT-tRNA中间体的乒乓机制,该酶通过修饰的碱基preQ 1(鸟嘌呤衍生物)催化tRNA的反密码子摆动位置中的鸟嘌呤交换(图2)。基于计算机建模(图3),林-benzoguanine(6-氨基咪唑并[4,5-克]喹唑啉-8-(7 ħ) -酮(2))被选作延伸的中心支架,与该蛋白质形成多达七个平面内分子间H键,同时夹在Tyr106和Met260之间。多功能的合成方案被用于合成开发2,和用苯基,苄基和2-苯乙基侧链(衍生物即,16,17A,和12A,12B,13,17,RESP)伸进林立的亲脂性口袋由Val282,Val45和Leu68设计(方案1-3)。考虑到新配体的溶解度有限,并且由于最近对TGT催化机理的详细了解(图2),对酶
  • Size-Expanded Analogues of dG and dC:  Synthesis and Pairing Properties in DNA
    作者:Haibo Liu、Jianmin Gao、Eric T. Kool
    DOI:10.1021/jo048357z
    日期:2005.1.1
    We describe the completion of the set of four benzo-fused expanded DNA (xDNA) nucleoside analogues. We previously reported the development of benzo-fused analogues of dA and dT and their inclusion in an exceptionally stable new four-base genetic system. termed xDNA. in which the base pairs were expanded in size. Here we describe the preparation and properties of the-second half of this nucleotide set: namely, the previously unknown dxC and dxG nucleosides. The dxC analogue was prepared from the previously reported dxT nucleoside in three steps and 57%, yield. The large-sized deoxyguanosine analogue was prepared from an intermediate in the synthesis of dxA, yielding dxG in 14 steps overall (2.4%). Suitably protected versions of the deoxynucleosides were prepared for oligonucleotide synthesis following standard procedures, and they were readily incorporated into DNA by automated synthesizer. "Dangling-end" measurements revealed that the benzo-fused homologues stack considerably more strongly on neighbor DNA sequences h do their natural counterparts. Base pairing experiments with xC or xG bases showed that they pair selectively with their Watson-Crick partners, but with mild destabilization. due apparently to their larger size. Overall, the data suggest that the fluorescent xG and xG bases may he useful probes of steric effects in the study of biological nucleotide recognition mechanisms. In addition. the completion of the xDNA nucleoside set makes it possible in the future to construct full four-base xDNA strands that can target any sequence of natural DNA and RNA.
  • Modifications on the heterocyclic base of acyclovir: syntheses and antiviral properties
    作者:Lilia M. Beauchamp、Bart L. Dolmatch、Howard J. Schaeffer、Peter Collins、D. J. Bauer、Paul M. Keller、James A. Fyfe
    DOI:10.1021/jm00146a002
    日期:1985.8
    A group of compounds was prepared in which variations of the ring portion of the acyclovir (ACV) structure were made. These modifications included monocyclic (isocytosine, triazole, imidazole), bicyclic (8-azapurine, pyrrolo[2,3-d]pyrimidine, pyrazolo[3,4-d]pyrimidine) and tricyclic (linear benzoguanine) congeners. The derivatives were evaluated against herpes simplex virus type 1 (HSV-1) by the plaque-inhibition and plaque-reduction methods with only the 8-azapurine analogue 28 showing some activity. In a test measuring the ability of these compounds to inhibit the HSV-1 thymidine kinase, 28 and the tricyclic derivative 38 exhibited competition with ACV for binding to the enzyme. The inability of the group to exert significant antiherpetic action is attributed to their lack of phosphorylation to the requisite triphosphate stage.
  • LEONARD N. J.; KAZMIERCZAK F.; RYKOWSKI A., J. ORG. CHEM., 52,(1987) N 13, 2933-2935
    作者:LEONARD N. J.、 KAZMIERCZAK F.、 RYKOWSKI A.
    DOI:——
    日期:——
  • LEONARD, NELSON J.;PETRIC, ANDREJ;RYKOWSKI, ANDRZEJ, J. ORG. CHEM., 53,(1988) N 16, C. 3873-3875
    作者:LEONARD, NELSON J.、PETRIC, ANDREJ、RYKOWSKI, ANDRZEJ
    DOI:——
    日期:——
查看更多